ATOS 8-K 2026-11-10

ATOSSA THERAPEUTICS, INC. (ATOS) 8-K dated 2026-11-10 — accession 0001193125-26-454486.

ATOSSA THERAPEUTICS, INC. (ATOS) is a biotechnology company listed on US.

ATOS: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Pr…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for ATOS is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The ATOS SEC hub lists recent forms. The stock page is the research view.